The present invention provides an early insulin secretion stimulator consisting of a triterpene represented by the following general formula (1) and/or a triterpene represented by the following general formula (2).
[where R1 represents COOH, etc., R11 and R12 represent CH2OH, etc., X1 represents hydrogen or OH and X11, X12, X21 and X22 represent OH, etc.]
Terpenoids. XXXI.<sup>1</sup> The Structure and Stereochemistry of Medicagenic Acid<sup>2</sup>
作者:Carl Djerassi、D. B. Thomas、A. L. Livingston、C. Ray Thompson
DOI:10.1021/ja01576a057
日期:1957.10
Insulin secretion potentiator
申请人:Matsuyama Futoshi
公开号:US20050143464A1
公开(公告)日:2005-06-30
The present invention provides early insulin secretion stimulators consisting of triterpenes represented by the following general formula (1) and/or triterpenes represented by the following general formula (2).
[where R
1
represents COOH, etc., R
11
and R
12
represent CH
2
OH, etc., X
1
represents hydrogen or OH and X
11
, X
12
, X
21
and X
22
represent OH, etc.]
[EN] GLUCONEOGENESIS INHIBITING AGENT<br/>[FR] AGENTS D'INHIBITION DE LA GLUCONEOGENESE
申请人:USE TECHNO CORP
公开号:WO2006054370A1
公开(公告)日:2006-05-26
[EN] The present invention provides a gluconeogenesis inhibiting agent containing as an active ingredient corosolic acid, an analogous compound of corosolic acid, or a pharmaceutically acceptable salt thereof. [FR] La présente invention concerne un agent d'inhibition de la gluconéogenèse, contenant en tant qu'ingrédient actif de l'acide corosolique, un analogue de l'acide corosolique ou l'un de leurs sels pharmaceutiquement acceptables.